Pancreatic cancer: Helicobacter pylori colonization, N-Nitrosamine exposures, and ABO blood group

Molecular Carcinogenesis

Volumn 51, Issue 1, 2012, Pages 109-118

  Risch, Harvey A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Blood groups; Helicobacter pylori; Nitrosamines; Pancreatic neoplasms

Indexed keywords

BLOOD GROUP ANTIGEN; NITROSAMINE;

ARTICLE; BACTERIAL COLONIZATION; BACTERIAL VIRULENCE; BLOOD GROUP ABO SYSTEM; CANCER RISK; CARCINOGENICITY; CIGARETTE SMOKING; COCARCINOGENESIS; CONTROLLED STUDY; DIETARY INTAKE; DNA DAMAGE; DUODENUM ULCER; EPITHELIUM; GENE LOCUS; GENETIC ASSOCIATION; GENOTYPE; HELICOBACTER PYLORI; HUMAN; INFLAMMATION; NONHUMAN; PANCREAS CANCER; PANCREAS SECRETION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; STOMACH CANCER; STOMACH ULCER;

ABO BLOOD-GROUP SYSTEM; ADENOCARCINOMA; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; NITROSAMINES; PANCREATIC NEOPLASMS; RISK FACTORS; SMOKING; STOMACH;

EID: 83455196940     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20826     Document Type: Article

References (86)

1. American Cancer Society. Cancer facts & figures 2010. Atlanta, GA: American Cancer Society; 2010.
2. Ries LAG, Miller BA, Hankey BF, Kosary CL, Harras A, Edwards BK, editors. SEER cancer statistics review, 1973-1991: Tables and graphs. Bethesda, MD: National Cancer Institute; 1994. NIH Publ No. 94-2789.
3. Lowenfels AB, Maisonneuve P. Pancreatic cancer: Development of a unifying etiologic concept. Ann NY Acad Sci 1999; 880: 191-200.
4. IARC. IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans. Vol. 38, Tobacco smoking. Lyon, France: International Agency for Research on Cancer; 1986. pp. 279-284.
5. Amundadottir L, Kraft P, Stolzenberg-Solomon RZ, et al. Genome-wide association study identifies ABO blood group susceptibility variants for pancreatic cancer. Nat Genet 2009; 41: 986-990.
6. Clarke CA. Blood groups and disease. In: Steinberg AG, editor. Progress in medical genetics, Vol. 1. New York, NY: Grune and Stratton; 1961. pp. 81-119.
7. Edgren G, Hjalgrim H, Rostgaard K, et al. Risk of gastric cancer and peptic ulcers in relation to ABO blood type: A cohort study. Am J Epidemiol 2010; 172: 1280-1285.
8. Raderer M, Wrba F, Kornek G, et al. Association between Helicobacter pylori infection and pancreatic cancer. Oncology 1998; 55: 16-19.
9. Stolzenberg-Solomon RZ, Blaser MJ, Limburg PJ, et al. Helicobacter pylori seropositivity as a risk factor for pancreatic cancer. J Natl Cancer Inst 2001; 93: 937-941.
10. Nomura A, Stemmermann GN, Chyou PH, Perez-Perez GI, Blaser MJ. Helicobacter pylori infection and the risk for duodenal and gastric ulceration. Ann Int Med 1994; 120: 977-981.
11. Macafee AL. ABO blood groups and carcinoma of pancreas. Ulster Med J 1964; 33: 129-131.
12. Newell GR, Gordon JE, Monlezun AP, Horwitz JS. ABO blood groups and cancer. J Natl Cancer Inst 1974; 52: 1425-1430.
13. Vioque J, Walker AM. Cancer de pancreas y tipologia sanguinea ABO: Un estudio de casos y controles. Med Clin (Barc) 1991; 96: 761-764.
14. Annese V, Minervini M, Gabbrielli A, Gambassi G, Manna R. ABO blood groups and cancer of the pancreas. Int J Pancreatol 1990; 6: 81-88.
15. Risch HA, Yu H, Lu L, Kidd MS., ABO blood group, Helicobacter pylori seropositivity, and risk of pancreatic cancer: A case-control study. J Natl Cancer Inst 2010; 102: 502-505.
16. Wolpin BM, Chan AT, Hartge P, et al. ABO blood group and the risk of pancreatic cancer. J Natl Cancer Inst 2009; 101: 424-431.
17. Wolpin BM, Kraft P, Gross M, et al. Pancreatic cancer risk and ABO blood group alleles: Results from the pancreatic cancer cohort consortium. Cancer Res 2010; 70: 1015-1023.
18. Ben Q, Wang K, Yuan Y, Li Z. Pancreatic cancer incidence and outcome in relation to ABO blood groups among Han Chinese patients: A case-control study. Int J Cancer 2011; 128: 1179-1186.
19. Risch HA. Etiology of pancreatic cancer, with a hypothesis concerning the role of N-nitroso compounds and excess gastric acidity. J Natl Cancer Inst 2003; 95: 948-960.
20. Dembinski AB, Johnson LR. Stimulation of pancreatic growth by secretin, caerulein, and pentagastrin. Endocrinology 1980; 106: 323-328.
21. Lawson T, Kolar CH. Xenobiotic metabolism and toxic responses in pancreatic duct epithelial cells. In: Sirica AE, Longnecker DS, editors. Biliary and pancreatic ductal epithelia: Pathobiology and pathophysiology. New York, NY: Marcel Dekker; 1997. pp. 443-455.
22. Hecht SS. DNA adduct formation from tobacco-specific N-nitrosamines. Mutat Res 1999; 424: 127-142.
23. Howatson AG, Carter DC. Pancreatic carcinogenesis: Effect of secretin in the hamster-nitrosamine model. J Natl Cancer Inst 1987; 78: 101-105.
24. Longnecker DS. Clues from experimental models. In: Reber H, editor. Pancreatic cancer: Pathogenesis, diagnosis, and treatment. Totowa, NJ: Humana Press; 1998. pp. 53-70.
25. Kokkinakis DM, Reddy MK, Norgle JR, Baskaran K. Metabolism and activation of pancreas specific nitrosamines by pancreatic ductal cells in culture. Carcinogenesis 1993; 14: 1705-1709.
26. Kokkinakis DM, Subbarao V. The significance of DNA damage, its repair and cell proliferation during carcinogen treatment in the initiation of pancreatic cancer in the hamster model. Cancer Res 1993; 53: 2790-2795.
27. Anderson KE, Potter JD, Mack TM. Pancreatic cancer. In: Schottenfeld D, Fraumeni JF, Jr., editors. Cancer epidemiology and prevention. 2nd edition. New York, NY: Oxford University Press; 1996. pp. 725-771.
28. Tricker AR, Pfundstein B, Theobald E, Preussmann R, Spiegelhalder B. Mean daily intake of volatile N-nitrosamines from foods and beverages in West Germany in 1989-1990. Food Chem Toxicol 1991; 29: 729-732.
29. Mack TM, Yu MC, Hanisch R, Henderson BE. Pancreas cancer and smoking, beverage consumption, and past medical history. J Natl Cancer Inst 1986; 76: 49-60.
30. Norell SE, Ahlbom A, Erwald R, et al. Diet and pancreatic cancer: A case-control study. Am J Epidemiol 1986; 124: 894-902.
31. Falk RT, Pickle LW, Fontham ET, Correa P, Fraumeni JF, Jr. Life-style risk factors for pancreatic cancer in Louisiana: A case-control study. Am J Epidemiol 1988; 128: 324-336.
32. Howe GR, Jain M, Miller AB. Dietary factors and risk of pancreatic cancer: Results of a Canadian population-based case-control study. Int J Cancer 1990; 45: 604-608.
33. LaVecchia C, Negri E, D'Avanzo B, et al. Medical history, diet and pancreatic cancer. Oncology 1990; 47: 463-466.
34. Baghurst PA, McMichael AJ, Slavotinek AH, Baghurst KI, Boyle P, Walker AM. A case-control study of diet and cancer of the pancreas. Am J Epidemiol 1991; 134: 167-179.
35. Zheng W, McLaughlin JK, Gridley G, et al. A cohort study of smoking, alcohol consumption, and dietary factors for pancreatic cancer (United States). Cancer Causes Control 1993; 4: 477-482.
36. Lyon JL, Slattery ML, Mahoney AW, Robison LM. Dietary intake as a risk factor for cancer of the exocrine pancreas. Cancer Epidemiol Biomarkers Prev 37 1993; 2: 513-518.
37. Ghadirian P, Baillargeon J, Simard A, Perret C. Food habits and pancreatic cancer: A case-control study of the Francophone community in Montreal, Canada. Cancer Epidemiol Biomarkers Prev 1995; 4: 895-899.
38. Ji BT, Chow WH, Gridley G, et al. Dietary factors and the risk of pancreatic cancer: A case-control study in Shanghai China. Cancer Epidemiol Biomarkers Prev 1995; 4: 885-893.
39. Silverman DT, Swanson CA, Gridley G, et al. Dietary and nutritional factors and pancreatic cancer: A case-control study based on direct interviews. J Natl Cancer Inst 1998; 90: 1710-1719.
40. Stolzenberg-Solomon RZ, Pietinen P, Taylor PR, Virtamo J, Albanes D. Prospective study of diet and pancreatic cancer in male smokers. Am J Epidemiol 2002; 155: 783-792.
41. Michaud DS, Giovannucci E, Willett WC, Colditz GA, Fuchs CS. Dietary meat, dairy products, fat, and cholesterol and pancreatic cancer risk in a prospective study. Am J Epidemiol 2003; 157: 1115-1125.
42. Coss A, Cantor KP, Reif JS, Lynch CF, Ward MH. Pancreatic cancer and drinking water and dietary sources of nitrate and nitrite. Am J Epidemiol 2004; 159: 693-701.
43. Nöthlings U, Wilkens LR, Murphy SP, Hankin JH, Henderson BE, Kolonel LN. Meat and fat intake as risk factors for pancreatic cancer: The multiethnic cohort study. J Natl Cancer Inst 2005; 97: 1458-1465.
44. Larsson SC, Hakanson N, Permert J, Wolk A. Meat, fish, poultry and egg consumption in relation to risk of pancreatic cancer: A prospective study. Int J Cancer 2006; 118: 2866-2870.
45. Stolzenberg-Solomon RZ, Cross AJ, Silverman DT, et al. Meat and meat-mutagen intake and pancreatic cancer risk in the NIH-AARP cohort. Cancer Epidemiol Biomarkers Prev 2007; 16: 2664-2675.
46. Chan JM, Wang F, Holly EA. Pancreatic cancer, animal protein and dietary fat in a population-based study, San Francisco Bay Area, California. Cancer Causes Control 2007; 18: 1153-1167.
47. Aschebrook-Kilfoy B, Cross A, Stolzenberg-Solomon R, et al. Pancreatic cancer and exposure to nitrate and nitrite in the NIH-AARP Diet and Health Study. Am J Epidemiol 2011; 174: 305-315.
48. Parsonnet J. Helicobacter pylori. Infect Dis Clin North Am 1998; 12: 185-197.
49. Wan Y, Xu Y-Y, Jiang J-H, et al. Chinese literature associated with diagnosis of Helicobacter pylori. World J Gastroenterol 2004; 10: 231-233.
50. McColl KEL, El-Omar E. Helicobacter pylori and disturbance of gastric function associated with duodenal ulcer disease and gastric cancer. Scand J Gastroenterol 1996; 31: 32-37.
51. Lee A, Dixon MF, Danon SJ, et al. Local acid production and Helicobacter pylori: A unifying hypothesis of gastroduodenal disease. Eur J Gastroenterol Hepatol 1995; 7: 461-465.
52. Sande N, Nikulin M, Nilsson I, et al. Increased risk of developing atrophic gastritis in patients infected with CagA+ Helicobacter pylori. Scand J Gastroenterol 2001; 36: 928-933.
53. Tzaneva M. Light and electron microscopic immunohistochemical investigation on G and D cells in antral mucosa in Helicobacter pylori-related gastritis. Exp Toxicol Pathol 2001; 52: 523-528.
54. Sumii M, Sumii K, Tari A, et al. Expression of antral gastrin and somatostatin mRNA in Helicobacter pylori-infected subjects. Am J Gastroenterol 1994; 89: 1515-1519.
55. Walsh JH. Gastrointestinal hormones. In: Johnson LR, Alpers DH, Christensen J, Jacobson ED, Walsh JH, editors. Physiology of the gastrointestinal tract. 3rd edition. New York, NY: Raven Press; 1994. pp. 1-128.
56. Haarstad H, Petersen H. Short- and long-term effects of secretin and a cholecystokinin-like peptide on pancreatic growth and synthesis of RNA and polyamines. Scand J Gastroenterol 1989; 24: 721-732.
57. Wadström T, Fryzek JP, Demirjian S, et al. Antibodies to Helicobacter bilis in patients with pancreatic carcinoma. Helicobacter 2004; 9: 538.
58. Kosunen TU, Pukkala E, Seppälä K, et al. The effect of eradication therapy for Helicobacter infection on the incidence of gastric and other cancers. Helicobacter 2004; 9: 534.
59. Lindkvist B, Johansen D, Borgström A, Manjer J. A prospective study of Helicobacter pylori in relation to the risk for pancreatic cancer. BMC Cancer 2008; 8: 321-329.
60. de Martel C, Llosa AE, Friedman GD, et al. Helicobacter pylori infection and development of pancreatic cancer. Cancer Epidemiol Biomarkers Prev 2008; 17: 1188-1194.
61. Chen W, Shu D, Chadwick VS. Helicobacter pylori infection: Mechanism of colonization and functional dyspepsia. Reduced colonization of gastric mucosa by Helicobacter pylori in mice deficient in interleukin-10. J Gastroenterol Hepatol 2001; 16: 377-383.
62. Jung HC, Kim JM, Song IS, Kim CY. Helicobacter pylori induces an array of pro-inflammatory cytokines in human gastric epithelial cells: Quantification of mRNA for interleukin-8, -1 alpha/beta, granulocyte-macrophage colony-stimulating factor, monocyte chemoattractant protein-1 and tumour necrosis factor-alpha. J Gastroenterol Hepatol 1997; 12: 473-480.
63. El-Omar EM. The importance of interleukin 1beta in Helicobacter pylori associated disease. Gut 2001; 48: 743-747.
64. Hall SK, Perregaux DG, Gabel CA, et al. Correlation of polymorphic variation in the promoter region of the interleukin-1 beta gene with secretion of interleukin-1 beta protein. Arthritis Rheum 2004; 50: 1976-1983.
65. Figueiredo C, Machado JC, Pharoah P, et al. Helicobacter pylori and interleukin-I genotyping: an opportunity to identify high risk individuals for gastric carcinoma. J Natl Cancer Inst 2002; 94: 1680-1687.
66. Persson C, Canedo P, Machado JC, El-Omar EM, Forman D. Polymorphisms in inflammatory response genes and their association with gastric cancer: A HuGE systematic review and meta-analysis. Am J Epidemiol 2011; 173: 259-270.
67. Palli D, Masala G, Del Giudice G, et al. CagA+ Helicobacter pylori infection and gastric cancer risk in the EPIC-EURGAST study. Int J Cancer 2006; 120: 859-867.
68. Suzuki G, Cullings H, Fujiwara S, et al. Low-positive antibody titer against Helicobacter pylori cytotoxin-associated gene A (CagA) may predict future gastric cancer better than simple seropositivity against H. pylori CagA or against H. pylori. Cancer Epidemiol Biomarkers Prev 2007; 16: 1224-1228.
69. Suriani R, Colozza M, Cardesi E, et al. CagA and VacA Helicobacter pylori antibodies in gastric cancer. Can J Gastroenterol 2008; 22: 255-258.
70. Aspholm-Hurtig M, Dailide G, Lahmann M, et al. Functional adaptation of BabA, the H. pylori ABO blood group antigen binding adhesion. Science 2004; 35: 519-522.
71. Lindén S, Mahdavi J, Semino-Mora C, et al. Role of ABO secretor status in mucosal innate immunity and H. pylori infection. PLoS Pathogens 2008; 4: 7-13.
72. Buchanan JA, Higley ED. The relationship of blood-groups to disease. Br J Exp Pathol 1921; 2: 247-255.
73. Macafee AL. ABO blood groups and gastric ulcer. J Med Genet 1965; 2: 24-25.
74. Polk DB, Peek RM, Jr. Helicobacter pylori: Gastric cancer and beyond. Nat Rev Cancer 2010; 10: 403-414.
75. Alkout AM, Blackwell CC, Weir DM, et al. Isolation of a cell surface component of Helicobacter pylori that binds H type 2, Lewis a, and Lewis b antigens. Gastroenterology 1997; 112: 1179-1187.
76. Azevedo M, Eriksson S, Mendes N, et al. Infection by Helicobacter pylori expressing the BabA adhesin is influenced by the secretor phenotype. J Pathol 2008; 215: 308-316.
77. Erzin Y, Koksal V, Altun S, et al. Prevalence of Helicobacter pylori vacA, cagA, cagE, iceA, babA2 genotypes and correlation with clinical outcome in Turkish patients with dyspepsia. Helicobacter 2006; 11: 574-580.
78. Gerhard M, Lehn N, Neumayer N, et al. Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesion. Proc Nat Acad Sci 1999; 96: 12778-12783.
79. Lee HS, Choe G, Kim WH, Kim HH, Song J, Park KU. Expression of Lewis antigens and their precursors in gastric mucosa: Relationship with Helicobacter pylori infection and gastric carcinogenesis. J Pathol 2006; 209: 88-94.
80. Prinz C, Schöniger M, Rad R, et al. Key importance of the Helicobacter pylori adherence factor blood group antigen binding adhesion during chronic gastric inflammation. Cancer Res 2001; 61: 1903-1909.
81. Mahdavi J, Sondén B, Hurtig M, et al. Helicobacter pylori SabA adhesion in persistent infection and chronic inflammation. Science 2002; 297: 573-578.
82. Yamaoka Y, Ojo O, Fujimoto S, et al. Helicobacter pylori outer membrane proteins and gastroduodenal disease. Gut 2006; 55: 775-781.
83. Ikehara Y, Nishihara S, Yasutomi H, et al. Polymorphisms of two Fucosyltransferase Genes (Lewis and Secretor Genes) involving Type I Lewis antigens are associated with the presence of anti-Helicobacter pylori IgG antibody. Cancer Epidemiol Biomarkers Prev 2001; 10: 971-977.
84. Heneghan MA, Moran AP, Feeley KM, et al. Effect of host Lewis and ABO blood group antigen expression on Helicobacter pylori colonisation density and the consequent inflammatory response. FEMS Immunol Med Microbiol 1998; 20: 257-266.
85. Kusters JG, van Vliet AH, Kuipers EJ. Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev 2006; 19: 449-490.
86. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188.